Results 221 to 230 of about 72,405 (280)

NeoThy™ immune-humanized mice can produce anti-drug antibodies to support immunogenicity assessment for biological drug products. [PDF]

open access: yesFront Immunol
Gharaie S   +10 more
europepmc   +1 more source

Protocol: Early Intestinal Ultrasonography for Prediction of Response to Corticosteroids or Biologics in Outpatients With Moderate to Severe Ulcerative Colitis

open access: yesJCC Plus, Volume 1, Issue 6, November 2026.
A prospective study of 150 outpatients with moderate‐to‐severe UC initiating treatment. IUS is performed at baseline, day‐2, ‐7, ‐90 and week 52 alongside clinical, biochemical, endoscopic, patient‐reported and exploratory multiomics assessments. The primary endpoint evaluates whether early change in BWT predicts treatment escalation within 3 and 12 ...
Sabrina Josefsen   +6 more
wiley   +1 more source

10 Years Since the LIR!C Trial: Old News or New Beginnings?

open access: yesJCC Plus, Volume 1, Issue 6, November 2026.
ABSTRACT In many patients with Crohn's disease, disease is initially confined to the ileocaecal region. The landmark LIR!C trial published in 2017 demonstrated that in localised ileocaecal disease refractory to standard immunomodulating therapy, primary ileocaecal resection led to similar outcomes concerning quality of life and remission as therapy ...
Paul Griebel
wiley   +1 more source

Sex Differences in Growth Recovery among Children with Crohn's Disease. [PDF]

open access: yesGut Liver
Kim DU   +19 more
europepmc   +1 more source

Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome

open access: yes
HemaSphere, Volume 10, Issue 11, November 2026.
Bhavisha A. Patel   +34 more
wiley   +1 more source

Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort study. [PDF]

open access: yesCrohns Colitis 360
Vuijk SA   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy